Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection
Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were fro...
Saved in:
| Published in: | Journal of clinical microbiology Vol. 49; no. 11; p. 3750 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.11.2011
|
| Subjects: | |
| ISSN: | 1098-660X, 1098-660X |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens. |
|---|---|
| AbstractList | Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens. Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens.Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens. |
| Author | Pettigrew, Melinda M Chonmaitree, Tasnee Gent, Janneane F Miller, Aaron L Nokso-Koivisto, Johanna Pyles, Richard B |
| Author_xml | – sequence: 1 givenname: Melinda M surname: Pettigrew fullname: Pettigrew, Melinda M email: melinda.pettigrew@yale.edu organization: Yale School of Public Health, Yale School of Medicine, New Haven, CT 06520-8034, USA. melinda.pettigrew@yale.edu – sequence: 2 givenname: Janneane F surname: Gent fullname: Gent, Janneane F – sequence: 3 givenname: Richard B surname: Pyles fullname: Pyles, Richard B – sequence: 4 givenname: Aaron L surname: Miller fullname: Miller, Aaron L – sequence: 5 givenname: Johanna surname: Nokso-Koivisto fullname: Nokso-Koivisto, Johanna – sequence: 6 givenname: Tasnee surname: Chonmaitree fullname: Chonmaitree, Tasnee |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21900518$$D View this record in MEDLINE/PubMed |
| BookMark | eNpN0D1PwzAQBmALFVFa2JiRN6YUn5sPe0QVnypiAcQWXZwzckmTYDtD_z0BisR070mvHuluxiZt1xJjZyAWAFJdPqweFwJA5QnAATsGoVWS5-Jt8i9P2SyEjRCQpll2xKYStBAZqGO2eXUem6RCE8k7bLhrxzBurmsDx7bm3oUP3lmOZojEu-iiC3xLtUNuum3fOIPRte986Hvy3FPoRzF2fsfjtzOCln64E3ZosQl0up9z9nJz_by6S9ZPt_erq3ViMpHHRFmDNWplCqugUtXSyrQmhXmB2bICRUYVwiBqKmogLYUhaStYatJ5YYHknF38ur3vPgcKsdy6YKhpsKVuCKUWkKdSi3Rsnu-bQzVeVPbebdHvyr_3yC95PGug |
| CitedBy_id | crossref_primary_10_1007_s00430_013_0293_2 crossref_primary_10_1007_s40272_013_0044_2 crossref_primary_10_3389_fcimb_2014_00194 crossref_primary_10_1136_archdischild_2013_304681 crossref_primary_10_1093_cid_ciu303 crossref_primary_10_1128_JCM_01146_16 crossref_primary_10_1111_mmi_13698 crossref_primary_10_3389_fimmu_2018_02275 crossref_primary_10_1038_pr_2012_179 crossref_primary_10_1038_nrdp_2016_63 crossref_primary_10_1016_j_arr_2015_07_005 crossref_primary_10_1073_pnas_1603007113 crossref_primary_10_33667_2078_5631_2025_19_72_79 crossref_primary_10_1111_2049_632X_12216 crossref_primary_10_1128_JCM_00330_18 crossref_primary_10_1093_cid_ciu716 crossref_primary_10_1093_cid_ciae104 crossref_primary_10_1002_jmv_23455 crossref_primary_10_1128_IAI_01478_15 crossref_primary_10_22207_JPAM_16_2_66 crossref_primary_10_1002_lary_25762 crossref_primary_10_1371_journal_pone_0328651 crossref_primary_10_1093_cid_cix941 crossref_primary_10_1016_j_prrv_2012_04_002 crossref_primary_10_1093_cid_ciy750 crossref_primary_10_1128_mSphere_00286_18 crossref_primary_10_1016_j_anl_2024_01_002 crossref_primary_10_1097_INF_0b013e31827d104e crossref_primary_10_1186_s40814_018_0337_x crossref_primary_10_1016_j_vetmic_2016_03_020 crossref_primary_10_3389_fmicb_2024_1345027 crossref_primary_10_1097_INF_0000000000002256 crossref_primary_10_1371_journal_pone_0095160 crossref_primary_10_3389_fgene_2019_01230 crossref_primary_10_1155_2013_210490 crossref_primary_10_1177_014556131609500908 crossref_primary_10_1093_infdis_jit317 crossref_primary_10_3389_fmicb_2019_02412 crossref_primary_10_1007_s10096_013_1858_0 crossref_primary_10_1093_pch_21_1_39 crossref_primary_10_1007_s40136_017_0152_6 crossref_primary_10_1177_01455613211009151 crossref_primary_10_1002_jmv_27151 crossref_primary_10_1177_17534259221123309 crossref_primary_10_1016_j_vaccine_2019_03_013 crossref_primary_10_1164_rccm_201510_2000OC crossref_primary_10_1134_S0006297916110110 crossref_primary_10_1177_11786361221104446 crossref_primary_10_1128_microbiolspec_GPP3_0004_2018 crossref_primary_10_1016_j_apr_2021_101198 crossref_primary_10_1016_j_mib_2016_11_003 crossref_primary_10_1038_s41522_024_00481_0 crossref_primary_10_1097_MOP_0000000000000184 crossref_primary_10_1586_ers_12_32 crossref_primary_10_1177_0194599816639028 crossref_primary_10_1007_s12105_021_01378_6 crossref_primary_10_1371_journal_pone_0170120 crossref_primary_10_1371_journal_ppat_1003057 crossref_primary_10_3390_cells11050916 crossref_primary_10_1097_INF_0000000000004939 crossref_primary_10_3389_fimmu_2017_01610 crossref_primary_10_1097_INF_0000000000000733 crossref_primary_10_3389_fcimb_2021_764772 crossref_primary_10_1097_INF_0000000000002486 crossref_primary_10_1002_ppul_24715 crossref_primary_10_1007_s15010_024_02305_x crossref_primary_10_1016_j_jiac_2016_06_001 crossref_primary_10_1016_j_jcv_2015_06_005 crossref_primary_10_1016_j_jinf_2012_12_002 crossref_primary_10_1016_j_vaccine_2017_07_027 crossref_primary_10_1016_j_jinf_2017_04_003 crossref_primary_10_1177_0194599816643510 crossref_primary_10_1038_mi_2015_1 crossref_primary_10_1038_s41522_019_0105_6 crossref_primary_10_1002_1873_3468_13697 crossref_primary_10_1093_femsle_fnv062 crossref_primary_10_3390_microorganisms9061181 crossref_primary_10_1016_j_ijid_2022_02_040 crossref_primary_10_7759_cureus_64539 crossref_primary_10_1099_jmm_0_000810 crossref_primary_10_4103_1012_5574_133179 crossref_primary_10_1371_journal_ppat_1003709 crossref_primary_10_1186_1471_2431_12_87 crossref_primary_10_3389_fmicb_2023_1279159 crossref_primary_10_3390_children12040397 crossref_primary_10_1007_s11882_012_0303_2 crossref_primary_10_1111_irv_12174 crossref_primary_10_1128_Spectrum_01246_21 crossref_primary_10_1016_j_jpeds_2014_12_067 crossref_primary_10_1093_infdis_jiz193 crossref_primary_10_1097_INF_0000000000001412 crossref_primary_10_1016_j_vaccine_2013_03_024 crossref_primary_10_1542_peds_2015_3555 crossref_primary_10_1097_PCC_0000000000003017 crossref_primary_10_1128_IAI_00727_17 crossref_primary_10_1097_INF_0b013e31826f6144 crossref_primary_10_1097_INF_0b013e31827687fc crossref_primary_10_1097_IM9_0000000000000081 crossref_primary_10_1128_AEM_01051_12 crossref_primary_10_1080_00325481_2015_1028872 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/JCM.01186-11 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1098-660X |
| ExternalDocumentID | 21900518 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDCD NIH HHS grantid: R01 DC005841 – fundername: NCRR NIH HHS grantid: UL1 RR029876 – fundername: NIAID NIH HHS grantid: R01 AI068043 – fundername: NCATS NIH HHS grantid: UL1 TR000071 – fundername: NIAID NIH HHS grantid: U54 AI057156 – fundername: NIAID NIH HHS grantid: AI057156 |
| GroupedDBID | --- .55 .GJ 0R~ 18M 29K 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS AAGFI ABOCM ABPPZ ACGFO ADBBV AENEX AGCDD AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CGR CS3 CUY CVF D-I DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HF~ HYE HZ~ H~9 KQ8 L7B NPM O9- OHT OK1 P2P P6G RHI RNS RPM RSF TR2 VH1 W8F WHG WOQ X7M ZCA ZGI ZXP ~KM 7X8 |
| ID | FETCH-LOGICAL-c506t-8fcada98c7f81b8b3f24de8a67a53b18ec870caa9e7d1e920ce2fb139e967f1e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 114 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000296617300005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1098-660X |
| IngestDate | Sun Nov 09 12:25:20 EST 2025 Mon Jul 21 06:06:07 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c506t-8fcada98c7f81b8b3f24de8a67a53b18ec870caa9e7d1e920ce2fb139e967f1e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3209086 |
| PMID | 21900518 |
| PQID | 901642904 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_901642904 pubmed_primary_21900518 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-11-01 |
| PublicationDateYYYYMMDD | 2011-11-01 |
| PublicationDate_xml | – month: 11 year: 2011 text: 2011-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of clinical microbiology |
| PublicationTitleAlternate | J Clin Microbiol |
| PublicationYear | 2011 |
| References | 9598849 - South Med J. 1998 May;91(5):433-6 20508481 - Pediatr Infect Dis J. 2010 Jun;29(6):557-8 16989632 - Expert Rev Vaccines. 2006 Aug;5(4):517-34 15992930 - J Infect. 2006 Mar;52(3):181-7 20415535 - J Infect Dis. 2010 Jun 1;201(11):1625-32 18245415 - Pediatrics. 2008 Feb;121(2):253-60 18756188 - Pediatr Infect Dis J. 2008 Oct;27(10):897-902 12692096 - Clin Microbiol Rev. 2003 Apr;16(2):230-41 17156899 - Vaccine. 2007 Feb 19;25(9):1683-9 7844685 - J Pediatr. 1995 Feb;126(2):313-6 20185098 - Lancet Infect Dis. 2010 Mar;10(3):195-203 6281639 - N Engl J Med. 1982 Jun 10;306(23):1377-83 18258088 - Emerg Infect Dis. 2008 Jan;14(1):101-6 19153302 - Arch Otolaryngol Head Neck Surg. 2009 Jan;135(1):17-21 20955085 - J Infect Dis. 2010 Nov 15;202(10):1617; author reply 1618 19935445 - Pediatr Infect Dis J. 2010 Apr;29(4):304-9 17083014 - Clin Infect Dis. 2006 Dec 1;43(11):1417-22 20646956 - J Clin Virol. 2010 Aug;48(4):239-45 20113572 - Emerg Infect Dis. 2010 Feb;16(2):324-7 11385510 - Nat Med. 2001 Jun;7(6):719-24 17263836 - Clin Microbiol Infect. 2007 May;13(5):504-9 15999017 - Pediatr Infect Dis J. 2005 Jul;24(7):655-7 19221788 - Eur J Pediatr. 2009 Nov;168(11):1365-72 16388486 - J Infect Dis. 2006 Feb 1;193(3):387-95 20833582 - J Clin Virol. 2010 Nov;49(3):158-62 16967296 - Eur J Pediatr. 2007 Mar;166(3):223-8 18205533 - Clin Infect Dis. 2008 Feb 15;46(4):e34-7 20134359 - Pediatr Infect Dis J. 2010 Jun;29(6):540-5 19690308 - JAMA. 2009 Aug 19;302(7):758-66 16118271 - Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6 15927278 - Antiviral Res. 2005 Aug;67(2):76-82 19843575 - J Leukoc Biol. 2010 Feb;87(2):213-22 20727478 - Diagn Microbiol Infect Dis. 2010 Sep;68(1):89-92 18279042 - Clin Infect Dis. 2008 Mar 15;46(6):815-23 17545372 - Pediatrics. 2007 Jun;119(6):1069-75 9920949 - N Engl J Med. 1999 Jan 28;340(4):260-4 16954253 - J Clin Microbiol. 2006 Sep;44(9):3231-5 |
| References_xml | – reference: 19935445 - Pediatr Infect Dis J. 2010 Apr;29(4):304-9 – reference: 12692096 - Clin Microbiol Rev. 2003 Apr;16(2):230-41 – reference: 20134359 - Pediatr Infect Dis J. 2010 Jun;29(6):540-5 – reference: 20727478 - Diagn Microbiol Infect Dis. 2010 Sep;68(1):89-92 – reference: 15992930 - J Infect. 2006 Mar;52(3):181-7 – reference: 17083014 - Clin Infect Dis. 2006 Dec 1;43(11):1417-22 – reference: 18245415 - Pediatrics. 2008 Feb;121(2):253-60 – reference: 11385510 - Nat Med. 2001 Jun;7(6):719-24 – reference: 16388486 - J Infect Dis. 2006 Feb 1;193(3):387-95 – reference: 19221788 - Eur J Pediatr. 2009 Nov;168(11):1365-72 – reference: 9920949 - N Engl J Med. 1999 Jan 28;340(4):260-4 – reference: 15999017 - Pediatr Infect Dis J. 2005 Jul;24(7):655-7 – reference: 16954253 - J Clin Microbiol. 2006 Sep;44(9):3231-5 – reference: 18205533 - Clin Infect Dis. 2008 Feb 15;46(4):e34-7 – reference: 16989632 - Expert Rev Vaccines. 2006 Aug;5(4):517-34 – reference: 20113572 - Emerg Infect Dis. 2010 Feb;16(2):324-7 – reference: 7844685 - J Pediatr. 1995 Feb;126(2):313-6 – reference: 16967296 - Eur J Pediatr. 2007 Mar;166(3):223-8 – reference: 17156899 - Vaccine. 2007 Feb 19;25(9):1683-9 – reference: 16118271 - Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6 – reference: 17263836 - Clin Microbiol Infect. 2007 May;13(5):504-9 – reference: 20955085 - J Infect Dis. 2010 Nov 15;202(10):1617; author reply 1618 – reference: 20185098 - Lancet Infect Dis. 2010 Mar;10(3):195-203 – reference: 19690308 - JAMA. 2009 Aug 19;302(7):758-66 – reference: 20833582 - J Clin Virol. 2010 Nov;49(3):158-62 – reference: 18756188 - Pediatr Infect Dis J. 2008 Oct;27(10):897-902 – reference: 20508481 - Pediatr Infect Dis J. 2010 Jun;29(6):557-8 – reference: 20415535 - J Infect Dis. 2010 Jun 1;201(11):1625-32 – reference: 19153302 - Arch Otolaryngol Head Neck Surg. 2009 Jan;135(1):17-21 – reference: 15927278 - Antiviral Res. 2005 Aug;67(2):76-82 – reference: 18258088 - Emerg Infect Dis. 2008 Jan;14(1):101-6 – reference: 6281639 - N Engl J Med. 1982 Jun 10;306(23):1377-83 – reference: 9598849 - South Med J. 1998 May;91(5):433-6 – reference: 17545372 - Pediatrics. 2007 Jun;119(6):1069-75 – reference: 19843575 - J Leukoc Biol. 2010 Feb;87(2):213-22 – reference: 18279042 - Clin Infect Dis. 2008 Mar 15;46(6):815-23 – reference: 20646956 - J Clin Virol. 2010 Aug;48(4):239-45 |
| SSID | ssj0014455 |
| Score | 2.4022698 |
| Snippet | Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 3750 |
| SubjectTerms | Child, Preschool Cohort Studies Comorbidity Haemophilus influenzae - isolation & purification Human bocavirus - isolation & purification Humans Infant Metapneumovirus - isolation & purification Microbial Interactions Moraxella (Branhamella) catarrhalis - isolation & purification Otitis Media - epidemiology Otitis Media - microbiology Otitis Media - virology Polymerase Chain Reaction Prospective Studies Respiratory Syncytial Viruses - isolation & purification Respiratory Tract Infections - complications Respiratory Tract Infections - microbiology Respiratory Tract Infections - virology Risk Assessment Streptococcus pneumoniae - isolation & purification |
| Title | Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21900518 https://www.proquest.com/docview/901642904 |
| Volume | 49 |
| WOSCitedRecordID | wos000296617300005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAAmLhUV7lJQ-spnGSJvaEUEWFkFp1AJStcuwzKkJJSFok_j22k9AJMbBkiWxF5_P54vvu-xC6NoeAjIFTQpVUJGQyJsILFEl1CuFA-_adE5uIJxOWJHzaYHOqBlbZxkQXqFUu7R15n1suKJ974W3xQaxolC2uNgoa66gTmEzGOnWcrIoIYehET6mlzIwiL2lx7z7rPw7HN7bnMiKU_p5bujNmtPfPr9tHu01yie9qbzhAa5B10VYtN_nVRdvjppB-iN5e5qV4J2nN1WzGWNqIsm5yqLDIFLaYc5xrLORyAdgi9uYVdn0meAVDz17xsiigxOWqYo8Xdh7coryyI_Q8un8aPpBGdoHIgRctCNNSKMHNsmmT07I00H6ogIkoFoMgpQyk2eNSCA6xosB9T4KvU2N_4FGsKfjHaCPLMzhFWFHtB0KYQ9LS1GvFGeOgmQrNb5TgkvUQbs05M25taxUig3xZzX4M2kMn9ZLMipp-Y2ZirA0l7Ozvwedox90Bu97BC9TRZkvDJdqUn8Zm5ZVzF_OcTMffH8TNKQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral-bacterial+interactions+and+risk+of+acute+otitis+media+complicating+upper+respiratory+tract+infection&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Pettigrew%2C+Melinda+M&rft.au=Gent%2C+Janneane+F&rft.au=Pyles%2C+Richard+B&rft.au=Miller%2C+Aaron+L&rft.date=2011-11-01&rft.eissn=1098-660X&rft.volume=49&rft.issue=11&rft.spage=3750&rft_id=info:doi/10.1128%2FJCM.01186-11&rft_id=info%3Apmid%2F21900518&rft_id=info%3Apmid%2F21900518&rft.externalDocID=21900518 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-660X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-660X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-660X&client=summon |